Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Angioplasty - New angioplasty research reported from University of Nebraska
Angioplasty - Research on angioplasty reported by A. Cohen et al
Biotech Business - Caprotec Bioanalytics Announces the Appointment of Funakoshi as Distributor for Its Products on the Japanese Market
Biotechnology - Study findings from University of Strathclyde broaden understanding of biotechnology
Clinical Trial Research - Orcrist Bio Inc. Files With European Competent Authority for a Phase I, Open-Label, Single-Ascending-Dose, Safety Study of HYC750
Clinical Trial Research - Studies from Erasme University provide new data on clinical trial research
Coagulation - ATryn® (Antithrombin [Recombinant]) Approved by the FDA
ConforMIS, Inc. - JFK Memorial Hospital Announces Availability of Personalized Partial Knee Resurfacing System for Patients
Cubist Pharmaceuticals, Inc. - Cubist Plans to Commence Patent Infringement Litigation against Teva Parenteral Medicines, Inc. In Response To ANDA filing
Darby & Darby P.C. - Michael K. Kirschner, Prominent Biotech Attorney, Joins Darby & Darby as Principal
Osmose - Consumer Safety and Product Performance of Micronized Copper Technology Confirmed
Ovarian Cancer - Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
Patents - Odyssey Thera Granted U.S. Patent for Novel GPCR Assay Strategy
Patents - Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Pharmacyclics, Inc. - Pharmacyclics Announces Appointment of New Management Team and Board Director to Accelerate Its Future Growth
pSivida Corp. - pSivida Corp. Reports Results for the Second Quarter Ended December 31, 2008; Iluvien™ NDA filing remains on schedule for early calendar 2010; Final two-year patient visit scheduled for October 2009
Research and Markets - "Neurostimulation Devices Pipeline Product and Technology Analysis Report" Will Allow You to Keep Abreast of the Very Latest Technological Developments
Research and Markets - Forecast Insight: Migraine - Generic Incursion Inhibits Market Growth
Research and Markets - Immunosuppressant Sales in the Seven Major Markets Are Expected To Grow To About $4.7 Billion Annually By 2011
Research and Markets - Minimize Risk Whilst Maximizing Return on Investment in Intellectual Property and Outsourcing in China
Research and Markets - Recently Updated Report Examines the Fundamentals of RNAi's Technologies, Markets and Companies
Ronald A. Katz Technology Licensing, L.P. - General Electric Company and Ronald A. Katz Technology Licensing, L.P. Settle Patent Lawsuit and Enter into License Agreement
The Female Health Company - The Female Health Company Expands and Extends Its Stock Repurchase Program
